Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of TC BioPharm (Holdings) plc from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: GBP
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
TC BioPharm (Holdings) plc annual and quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in GBP history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • TC BioPharm (Holdings) plc Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 31 Mar 2024 was £3,432,596, a 232% decline year-over-year.
  • TC BioPharm (Holdings) plc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2024 was £12,806,001, a 83% decline from 2023.
  • TC BioPharm (Holdings) plc annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was £6,995,682, a 131% decline from 2022.
Source SEC data
View on sec.gov
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (GBP)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Change (%)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (GBP)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (GBP)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 £12,806,001 -£5,810,319 -83% 01 Jan 2024 31 Dec 2024 20-F 09 May 2025 2024 FY
2023 £6,995,682 -£3,962,081 -131% 01 Jan 2023 31 Dec 2023 20-F 09 May 2025 2024 FY
2022 £3,033,601 01 Jan 2022 31 Dec 2022 20-F 09 May 2025 2024 FY

TC BioPharm (Holdings) plc Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (GBP)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 £3,432,596 -£2,397,685 -232% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q1 2023 £1,034,911 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.